Given its substantial growth in recent years and its potential for continued expansion driven by steady demand, the pharma industry exhibits resilience in times of economic instability.
Moreover, governments worldwide have recognized the critical role of maintaining the industry’s economic well-being and have introduced various reforms to strengthen its essential functions.
